Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

• Main Authors: Ashley Wysong (Author), Ally‐Khan Somani (Author), Sherrif F. Ibrahim (Author), Javier Cañueto (Author), Alison L. Fitzgerald (Author), Jennifer J. Siegel (Author), Anesh Prasai (Author), Matthew S. Goldberg (Author), Aaron S. Farberg (Author), Christie Regula (Author), Anna Bar (Author), Julia Kasprzak (Author), David G. Brodland (Author), Shlomo A. Koyfman (Author), Sarah T. Arron (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction The validated 40-gene expression profile (40-GEP) test independently stratifies risk of regional or distant metastasis for cutaneous squamous cell carcinoma (cSCC) tumors with high-risk clinicopathologic features. This study evaluated the stratification of risk by the 40-GEP te...